miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway

Liang Shi(National Instruments (Ireland)), Fang Zheng(Ministry of Education of the People's Republic of China), Jianjian Zheng(Wenzhou Medical University), Xiangyang Lin, Liu Cun-li, Zengqiang Chen(Nankai University), Sheng-Ying Chi, Xiaofei Chen, Lili Wu(Tumor Hospital of Guangxi Medical University), Jianrong Yang, Jiaying Zheng(Chinese University of Hong Kong), Haixia Huang, Zhanguo Chen
Asian Pacific Journal of Cancer Prevention
January 6, 2015
Cited by 89


Related Papers